Paper · 36922653
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney.
Bayır H and 4 others. Nat Rev Nephrol, 2023. Cited by 281 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Papers, record 36922653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36922653
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Iron | Major topic |
| Ferroptosis | Major topic |
| Humans | |
| Lipid Peroxidation | |
| Oxidation-Reduction | |
| Kidney |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA266342 | NCI NIH HHS | United States | R01CA266342 | PubMed and NIH | NIH RePORTER |
| UG3 DK114861 | NIDDK NIH HHS | United States | UG3DK114861 | PubMed and NIH | NIH RePORTER |
| R01 CA165065 | NCI NIH HHS | United States | R01CA165065 | PubMed and NIH | NIH RePORTER |
| U01 AI156924 | NIAID NIH HHS | United States | U01AI156924 | PubMed and NIH | NIH RePORTER |
| P01 HL114453 | NHLBI NIH HHS | United States | P01HL114453 | PubMed and NIH | NIH RePORTER |
| R01 AI145406 | NIAID NIH HHS | United States | R01AI145406 | PubMed and NIH | NIH RePORTER |
| R01 GM122923 | NIGMS NIH HHS | United States | R01GM122923 | PubMed and NIH | NIH RePORTER |
| R01NS076511 | NIH | NIH RePORTER | |||
| R37NS061817 | NIH | NIH RePORTER | |||
| U01AI156923 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References280
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,190,609 | Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. | Cell Death Dis | 2012 | https://conductscience.org/library/papers/23190609 | PubMed |
| 2 | 24,899,309 | Pro-resolving lipid mediators are leads for resolution physiology. | Nature | 2014 | https://conductscience.org/library/papers/24899309 | PubMed |
| 3 | 36,109,647 | Hydropersulfides inhibit lipid peroxidation and ferroptosis by scavenging radicals. | Nat Chem Biol | 2023 | https://conductscience.org/library/papers/36109647 | PubMed |
| 4 | 6,059,205 | Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine. | Am Rev Respir Dis | 1967 | https://conductscience.org/library/papers/6059205 | PubMed |
| 5 | 24,880,340 | Identification of erythroferrone as an erythroid regulator of iron metabolism. | Nat Genet | 2014 | https://conductscience.org/library/papers/24880340 | PubMed |
| 6 | 16,144,837 | Redox imbalance in cystine/glutamate transporter-deficient mice. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16144837 | PubMed |
| 7 | 30,996,346 | Fatty acid transport protein 2 reprograms neutrophils in cancer. | Nature | 2019 | https://conductscience.org/library/papers/30996346 | PubMed |
| 8 | 33,665,270 | Lipidomics data showing the effect of lipofermata on myeloid-derived suppressor cells in the spleens of tumor-bearing mice. | Data Brief | 2021 | https://conductscience.org/library/papers/33665270 | PubMed |
| 9 | 33,558,472 | Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33558472 | PubMed |
| 10 | 10,652,280 | Early embryonic lethality of H ferritin gene deletion in mice. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10652280 | PubMed |
1 to 10 of 280
See all 280 referencesCited by187
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,964,669 | Circadian rhythm dysregulation and ferroptosis in hypertension: mechanisms and therapeutic implications. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42964669 | PubMed |
| 42,960,598 | NADPH oxidase-associated oxidative stress and ferroptosis-related injury in calcium oxalate-exposed renal tubular epithelial cells: pharmacological evidence for PI3K/AKT involvement. | Ren Fail | 2026 | https://conductscience.org/library/papers/42960598 | PubMed |
| 42,943,481 | Time-Series Multi-Omics Reveal Metabolic Reprogramming, Oxidative Stress and Programmed Cell Death in M. bovis-Infected Bovine Mammary Epithelial Cells. | Microorganisms | 2026 | https://conductscience.org/library/papers/42943481 | PubMed |
| 42,942,016 | Lipid Metabolism and Ferroptosis in Cancer: Regulatory Mechanisms, Alternative Splicing, and Therapeutic Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942016 | PubMed |
| 42,939,868 | Metabolomic and Transcriptomic Changes in Porcine Cumulus-Oocyte Complexes Following Vitrification: Cysteinyl-Glycine as an Antioxidant Enhances the Quality of Vitrified Oocytes. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42939868 | PubMed |
| 42,939,350 | The Iron-Mitochondria-Oligodendrocyte Axis: An Emerging Metabolic Framework for Alzheimer's Disease. | Brain Sci | 2026 | https://conductscience.org/library/papers/42939350 | PubMed |
| 42,920,733 | Metabolic reprogramming and metabolic homeostasis in podocyte injury: novel mechanistic insights and natural product therapies. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42920733 | PubMed |
| 42,920,026 | Ferroptosis in health and disease. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42920026 | PubMed |
| 42,908,614 | Mapping the aging kidney: a bibliometric atlas of cellular senescence and future frontiers since the 20th century. | Front Nephrol | 2026 | https://conductscience.org/library/papers/42908614 | PubMed |
| 42,807,112 | Artesunate alleviates cisplatin-induced nephrotoxicity by regulating tryptophan metabolism and inhibiting ferroptosis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42807112 | PubMed |
1 to 10 of 187
See all 187 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GPX4 | 2,879 | PubTator's text mining | https://conductscience.org/library/genes/2879 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36922653
GET https://conductscience.org/api/papers/v1/36922653/references?page=2